The purinergic P2X2 receptor (P2X2R) is an adenosine triphosphate-gated ion channel widely expressed in the nervous system. Here, we identified a putative cyclin-dependent kinase 5 (Cdk5) phosphorylation site in the full-size variant P2X2aR ( 372 TPKH 375 ), which is absent in the splice variant P2X2bR. We therefore investigated the effects of Cdk5 and its neuronal activator, p35, on P2X2aR function. We found an interaction between P2X2aR and Cdk5/p35 by co-immunofluorescence and co-immunoprecipitation in HEK293 cells. We also found that threonine phosphorylation was significantly increased in HEK293 cells co-expressing P2X2aR and p35 as compared to cells expressing only P2X2aR. Moreover, P2X2aR-derived peptides encompassing the Cdk5 consensus motif were phosphorylated by Cdk5/p35. Whole-cell patch-clamp recordings indicated a delay in development of use-dependent desensitization (UDD) of P2X2aR but not of P2X2bR in HEK293 cells co-expressing P2X2aR and p35. In Xenopus oocytes, P2X2aRs showed a slower UDD than in HEK293 cells and Cdk5 activation prevented this effect. A similar effect was found in P2X2a/3R heteromeric currents in HEK293 cells. The P2X2aR-T372A mutant was resistant to UDD. In endogenous cells, we observed similar distribution between P2X2R and Cdk5/p35 by co-localization using immunofluorescence in primary culture of nociceptive neurons. Moreover, co-immunoprecipitation experiments showed an interaction between Cdk5 and P2X2R in mouse trigeminal ganglia. Finally, endogenous P2X2aR-mediated currents in PC12 cells and P2X2/3R mediated increases of intracellular Ca 21 in trigeminal neurons were Cdk5 dependent, since inhibition with roscovitine accelerated the desensitization kinetics of these responses. These results indicate that the P2X2aR is a novel target for Cdk5-mediated phosphorylation, which might play important physiological roles including pain signaling.
Introduction
The cyclin-dependent kinase 5 (Cdk5) is an emergent and essential kinase involved in the physiology of sensory pathways. 41, 52 Cdk5 plays key roles in brain development and function, including neuronal migration, membrane transport, axon guidance, and pain signaling. 19, 20, 52 Although Cdk5 is ubiquitously expressed, it is mostly active in postmitotic neurons, where its specific activators p35 and p39 are mainly expressed. 19, 30, 55 Cdk5 is a prolinedirected serine/threonine kinase that phosphorylates many proteins, including cytoskeletal proteins, ion channels, and regulatory proteins. 2 We reported earlier that Cdk5 regulates pain signaling in nociceptive neurons of the dorsal root ganglion (DRG) and trigeminal ganglion (TG). 41, 46, 47, 52 The Cdk5 activity increases during peripheral inflammation, by the action of cytokines such as TNF-a 47, 53, 57 and TGF-b1. 54 , 56 Moreover, we found that Cdk5 phosphorylates the transient receptor potential vanilloid 1 (TRPV1) in Thr407, a key ion channel implicated in pain, increasing its function. 25, 33, 40, 47, 54, 56 Remarkably, TRPV1 is phosphorylated in Ser116 and Thr370 by PKA, 35 and its dephosphorylation is important for the desensitization process. 36 Interestingly, other channels such as the purinergic P2X receptors (P2XRs) also contribute to pain signaling. However, their functional modulation by Cdk5 has not been deeply analyzed.
The P2XRs are a family of extracellular adenosine triphosphate (ATP)-gated ionic channels, widely expressed in different tissues and involved in several physiological and pathophysiological processes. 7, 49 The P2X2R is one of the most abundant subtypes in the nervous system and its subunits can form homomeric or heteromeric channels with P2X3R subunit (P2X2/3R), which are Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article.
expressed in nociceptive neurons and their activation is involved in pain signaling. 8, 9 Several functional splice variants of P2X2R exist, 13 that differ in their desensitization properties; eg, the shorter variant P2X2bR lacks 69 amino acids in the intracellular Cterminal domain and desensitizes faster than the full-length P2X2aR. 5, 28, 48 Compared to other P2XR subtypes, P2X2Rs exhibit slow desensitization profile, which depends on agonist and Ca 21 concentration, and in N-and C-terminal residues/ domains. 13, 14, 27 The gating properties of P2X2R are also affected by protons, divalent metals, 11, 34 reactive oxygen species, 12 steroid hormones, 18 and membrane phosphoinositides, 22 all these molecules act as allosteric regulators. Additionally, phosphorylation of P2X2R by PKA and PKC also regulates its gating properties. 3, 16 Here, we show that Cdk5 regulates the activity of P2X2R, by phosphorylation of Thr372, a residue exclusively present in the full-length P2X2aR but absent in P2X2bR. Using confocal microscopy, biochemical and electrophysiological techniques, we found that Cdk5/p35 physically interacts with P2X2R in heterologous overexpression systems, primary cultures of TG and DRG neurons, and in PC12 cells that endogenously express Cdk5/p35 and P2X2R. We also found that Cdk5/p35 can phosphorylate P2X2aR, regulating the gating properties that results in desensitization changes, in both heterologous and endogenous systems. These findings suggest that the P2X2aR is a new target for Cdk5-mediated phosphorylation, which might play an important role in pain signaling and therefore could be a potential novel target for developing pain therapies.
Methods

P2X2R and P2X2/3R expression in HEK293 cells and Xenopus laevis oocytes
HEK293 cells (ATCC# CRL-1573) were grown in Dulbecco modified Eagle medium containing 10% of fetal bovine serum (FBS) and penicillin/streptomycin (Invitrogen, Carlsbad, CA). For Western blot and co-immunoprecipitation analysis, HEK293 cells were transiently co-transfected during 24 hours with rat P2X2aR-pIRES-GFP or P2X2bR-pIRES-GFP in combination with mouse p35 and mouse Cdk5 vectors by using Lipofectamine 2000 reagent (Invitrogen). For immunofluorescence experiments, HEK293 cells were grown on 12-mm coverslips treated with poly-L-lysine and then transfected for 24 hours with rat P2X2aR-GFP fusion protein, mouse p35, and Cdk5 plasmids. For patch-clamp experiments, HEK293 cells were grown on 35-mm dishes at a density of 500,000 cells per plate and transfected with rat P2X2aR-pIRES-GFP, P2X2bR-pIRES-GFP, or P2X2aR-pIRES-GFP T372A mutant receptor with or without p35 vectors. For the experiments with the heteromeric P2X2/3R, we co-transfected rat P2X2aR-pIRES-GFP, rat P2X3R-pIRES-GFP, and p35 vector, and for the isolation of the heteromeric currents, we used the specific agonist a,b-methylene ATP (a,b-meATP). For experiments in Xenopus laevis oocytes, a segment of the ovary was surgically removed from female frogs under anesthesia with benzocaine 0.05% and oocytes were manually defolliculated and incubated with collagenase II (1 mg/mL). Each oocyte was injected intranuclearly with 3 to 5 ng of complementary DNA coding for the different P2X2Rs alone or combined with the p35 plasmid. Patch-clamp experiments for HEK293 cells and 2-electrode voltage-clamp experiments for Xenopus oocytes were performed 18 to 48 hours after transfection/injection.
Primary culture of neurons from mouse TG and DRG and rat TG
Nociceptive neurons were cultured as described previously. 47 Briefly, TG and DRG were dissected out from 2-to 4-month-old mice or rat and incubated with collagenase XI (0.66 mg/mL) and dispase II (3 mg/mL) (Sigma-Aldrich, San Louis, MO) in an INCmix solution (NaCl 155 mM; K 2 HPO 4 1.5 mM; HEPES 10 mM; glucose 5 mM; at pH 7.4). Enzymatic digestion was performed for 45 minutes at 37˚C in 5% CO 2 , and cells were cultured in minimum essential media (MEM) supplemented with 10% FBS, penicillin/streptomycin 100 mg/mL, and MEM-vit (Invitrogen). Cells were plated on 12-mm poly-L-lysine-coated glass coverslips and cultured for 2 days. Animal experiments were conducted in accordance with the principles and procedures of the National Institutes of Health Guidelines for the Care and Use of Laboratory and the Bioethical Committee of Universidad Católica del Norte, Coquimbo, and the Ethics Committee of the Biology Department, Faculty of Sciences, Universidad of Chile, Santiago, Chile.
PC12 cell culture
The PC12 cell line (ATCC# CRL-1721) was grown in Dulbecco modified Eagle medium containing 10% FBS, 5% horse serum, and penicillin/streptomycin. For immunofluorescence and electrophysiological recordings experiments, PC12 cells were plated on 12-mm coverslips treated with poly-L-lysine. For Cdk5 inhibition experiment, PC12 cells were treated with roscovitine 30 mM during 6 and 24 hours before electrophysiological recordings. To evaluate the current of P2X2aR or P2X2aR T372A mutant, we transfected those vectors in PC12 cells and current was measured 24 hours later.
Western blot analysis
Protein extracts from HEK293 cells, PC12 cells, or from mouse TG and DRG were obtained in T-PER buffer (Pierce, Rockford, IL) with Complete Mini protease inhibitor cocktail tablets and PhosSTOP phosphatase inhibitor cocktail tablets (Roche Diagnostic, Indianapolis, IN). Protein concentration was determined using the Bradford Protein Assay (Bio-Rad, Hercules, CA). Proteins were separated in sodium dodecyl sulfate polyacrylamide gel electrophoresis gels and transferred to nitrocellulose membranes (Invitrogen). Membranes were soaked in blocking buffer (5% nonfat dry milk in Tris-buffered saline with 0.05% Tween-20 for 1 hour at room temperature and then incubated overnight at 4˚C, with primary antibody diluted in 1% nonfat dry milk blocking buffer). The membranes were washed in Tris-buffered saline with 0.05% Tween-20 and incubated for 1 hour at room temperature with the secondary antibodies diluted in 1% nonfat dry milk blocking buffer. Immunoreactivity was detected by using Super-Signal West Pico or Dura Chemiluminescent Substrate (Thermo Scientific, Rockford, IL). Western blots were performed using P2X2R rabbit antibody #APR-003 and P2X3R rabbit antibody #APR-016 from Alomone Labs (Jerusalem, Israel); Cdk5 rabbit antibody C8, Cdk5 mouse antibody DC17, p35 rabbit antibody C19, and p35 goat antibody A18 from Santa Cruz Biotechnology (Dallas, TX); phospho-(Thr) MAPK/CDK substrate mouse antibody #2321, GFP rabbit antibody #2555, and p35 #2680 were obtained from Cell Signaling Technology; and a-tubulin antibody from SigmaAldrich was used as loading control. We also used a control peptide antigen from P2X2R sequence (Alomone Labs) as negative control for P2X2R Western blot and immunofluorescence experiments. The optical densities of the bands were quantified using an image analysis system with ImageJ 1.46r software (NIH, Bethesda, MD).
Co-immunoprecipitate assay
To evaluate the putative interaction between P2X2aR and Cdk5/ p35, we immunoprecipitated protein (IP) extracts (1 mg) from HEK293 cells co-transfected with P2X2aR-IRES-GFP and p35; or P2X2aR-IRES-GFP and Cdk5 plasmids, by using with 2 mg of rabbit p35 antibody (C19) or mouse Cdk5 antibody (DC17), respectively. In addition, we immunoprecipitated 350 mg of protein extracts from mouse TG by using 2 mg of rabbit Cdk5 (C8) antibody. The incubation of antibodies was performed for 4 hours at 4˚C with stirring followed by the addition of 25 mL of Protein A/G PLUS-agarose beads (Santa Cruz Biotechnology) incubated overnight at 4˚C with stirring. Immunoprecipitated proteins were washed by centrifugation at 2500 rpm at 4˚C 3 times in cold phosphate-buffered saline (PBS). Loading buffer was added to IPs and they were electrophoresed on sodium dodecyl sulfate polyacrylamide gel electrophoresis (protocol continues as Western blot analysis). To evaluate threonine phosphorylation of P2X2aR mediated by Cdk5/p35, we immunoprecipitated 300 mg of protein extracts from HEK293 cells co-transfected with P2X2aR-IRES-GFP with or without p35 plasmid by using 2 mg of P2X2R rabbit antibody #APR-003 from Alomone Labs and followed a Western blot against phospho-(Thr) MAPK/CDK substrate mouse antibody #2321. We used normal IgG goat antibody (#AB-108-C; R&D System, Minneapolis, MN) as IgG control. As negative control, we used protein extracts from HEK293 cells overexpressing P2X2aR and p35 or Cdk5 incubated only with Protein A/G PLUS-agarose beads without primary antibody.
Immunofluorescence analysis
We analyzed the co-localization of P2X2aR with Cdk5/p35 and the cellular localization of P2X2aR-T372A in HEK293 cells cotransfected with those vectors. Additionally, we analyzed the P2X2R and p35 endogen expression in PC12 cells. Furthermore, we examined the co-localization of endogen P2X2R and P2X3R, with p35 and Cdk5 in primary culture of neurons from mouse TG and DRG. Thus, transfected HEK293 cells, PC12 cells, or primary cultured neurons were washed with warm PBS for 5 minutes and fixed with a 4% PFA-4% sucrose solution in PBS at 37˚C for 20 minutes. After fixation, cells were washed 3 times with PBS and permeabilized for 5 minutes with a 0.2% Triton X-100 solution in PBS. After washout with PBS, cells were blocked with a 5% BSA solution in PBS at room temperature for 1 hour. Corresponding primary antibodies were used at following concentrations: antiCdk5 rabbit C8 (1:100) and anti-Cdk5 mouse DC17 (1:100) antibody (Santa Cruz Biotechnology); anti-p35 goat A18 (1:100) and anti-p35 rabbit C19 (1:100) antibody (Santa Cruz Biotechnology); MAP1B goat N-19 (1:200) antibody (Santa Cruz Biotechnology); anti-bIII tubulin mouse clone G7121 (1:1000) antibody (Promega); and P2X2R rabbit #APR-003 (1:250) antibody (Alomone Labs). All primary antibodies were diluted in 1% BSA solution and incubated overnight at 4˚C. The coverslips were washed with PBS and then incubated for 1 hour at room temperature with corresponding secondary antibodies: antirabbit conjugated to Alexa Fluor546, anti-mouse conjugated to Alexa Fluor488, and anti-goat conjugated to Alexa Fluor647 (Molecular Probes; Life Technologies, Grand Island, NY) in combination with Dapi (Thermo Fisher Scientific). Finally, coverslips were washed with PBS, then they were dried and mounted on a slide with FluorSave (Calbiochem) and then were observed using confocal microscopy (LSM 710 Meta Model; Carl Zeiss Microscopy) and processed with the LSM Image Browser (Carl Zeiss Microscopy) software.
Preparation of RNA and reverse transcription polymerase chain reaction
Conventional reverse transcription polymerase chain reaction (RT-PCR) was performed as described previously. 47 Briefly, total RNA was extracted from frozen DRGs and TGs from wild-type 5-month-old mice or from PC12 cells by using TRIzol Reagent (Invitrogen) according to the manufacturer's instructions. Total RNA was digested with TURBO DNase (Ambion, Austin, TX) for 1 hour to remove contaminating genomic DNA, and retrotranscription was carried out with M-MLV Reverse Transcriptase (Invitrogen) by using Oligo (dT). We analyzed messenger RNA levels of p35, Cdk5, P2X2R isoforms, P2X3R, and S29 by using 
In vitro phosphorylation of P2X2aR-based peptides
We identified a putative consensus motif for Cdk5 phosphorylation in P2X2aR protein sequence by using prediction websites Motif-Scan http://scansite.mit.edu/motifscan_seq.phtml and NetPhos2.0 http://www.cbs.dtu.dk/services/NetPhos/. To evaluate potential Cdk5 phosphorylation sites, 10 amino acid residues of P2X2aR peptides were tested in an in vitro Cdk5 kinase assay. Recombinant full-length human Cdk5 and p35 (Sigma) were incubated in 50 mL of kinase assay buffer (100 mM Tris-HCl [pH 7.4]; 50 mM MgCl 2 ; 5 mM EDTA; 50 mM NaF; 5 mM Na 2 VO 3 ; and 5 mM DTT) containing either 10 mg of histone H1 (Sigma) or P2X2aR peptides (mouse P2X2aR, KVRTPRHPSS; human P2X2aR, KVCTPSHPSG; rat P2X2aR, KVRTPKHPSS; and nonrelated peptide, IGQSPFHGDD). Kinase assays were carried out at 30˚C for 60 minutes by adding 5 mCi of [g-32 P] ATP (0.5 mM). The peptide assay was stopped by adding 10% trichloroacetic acid to precipitate proteins. Twenty-microliter aliquots of trichloroacetic acid supernatant were transferred onto P81 phosphocellulose squares (spotted in duplicates), air-dried, and washed 5 times for 15 minutes each in 75 mM phosphoric acid and once in 95% ethanol. After air drying, squares were transferred to vials containing Bio-Safe II scintillation fluid (Research Products International, Mount Prospect, IL) for counting in a Beckman Coulter (Fullerton, CA) scintillation counter (model SL 3801).
techniques. The currents were recorded using an Axopatch 200B patch-clamp amplifier (Molecular Devices) and were filtered at 2 kHz using a low-pass Bessel filter. Patch electrodes, fabricated from borosilicate glass (type 1B150F-3; World Precision Instruments), using a Flaming Brown horizontal puller (P-87; Sutter Instruments), were heat polished to a final tip resistance of 2 to 4 MV. All current records were captured and stored using the pClamp 9 software packages in conjunction with the Digidata 1322A analog-to-digital converter (Molecular Devices). Unless otherwise specified, patch electrodes were filled with a solution containing the following: 142 mM NaCl, 10 mM EGTA, and 10 mM HEPES. The osmolarity of the internal solutions was 305 mOsm. The bath solution (KR-like) contained the following: 142 mM NaCl, 3 mM KCl, 1 mM MgCl 2 , 2 mM CaCl 2 , 10 mM glucose, and 10 mM HEPES. The Ca 21 -free solution contained 145 mM NaCl, 3 mM KCl, 10 mM glucose, and 10 mM HEPES. In all cases, pH was adjusted to 7.35, and the osmolarity of those solutions was 295 to 305 mOsm. Adenosine triphosphate was daily prepared in bath buffer and applied using a rapid solution changer system (RSC-200; Biologic Science Instruments). The current responses were recorded from single cells clamped at 2 60 mV. Most of the data were collected from recordings of single cells stimulated with 10 mM of ATP with a washout interval of 4 minutes between each application and normalized to the highest current amplitude. For PC12 recordings of endogenous P2X2R-mediated currents, we used similar conditions to that used for HEK293 cells recordings, but the intracellular solution contained 5 mM ATP and 0.05 mM EGTA to observe the endogenous phosphorylation of the P2X2R by Cdk5. Roscovitine (30 mM) was incubated for 6 and 24 hours before experiments.
Current measurements in Xenopus oocytes
Oocytes were bathed in Barth solution (88 mM NaCl, 1 mM KCl, 2.4 mM NaHCO 3 , 10 mM HEPES, 0.82 mM MgSO 4 , 0.33 mM Ca (NO 3 ) 2 , and 0.91 mM CaCl 2 , pH 7.5) supplemented with 10 IU/L penicillin/10 mg streptomycin and 2 mM pyruvate; oocytes were clamped at 260 mV using the 2-electrode voltage-clamp configuration with an OC-725C clamper (Warner Instruments). The ATP-evoked currents were recorded after regular 1 to 1000 mM ATP applications, with washout periods ranging from 3 to 15 minutes depending on ATP concentration. For the experiments with allosteric modulators, oocytes expressing P2X2aR or P2X2aR-T372A vectors were challenged with 10 mM ATP that resulted in small, non-desensitizing currents. Copper, zinc, and PPADS solutions (selective P2XR antagonist) at a concentration of 10 mM were pre-applied for 1 minute and then were co-applied with ATP; the currents induced by this application were compared to that induced by ATP alone. For the pH experiments, the ATP-containing solution was adjusted to pH 6.5 and the currents induced by this solution were compared to the currents induced by ATP at pH 7.5.
Intracellular Ca 21 measurements in cultured TG neurons
Primary cultured TG neurons were loaded with Fluo4-AM (3 mM in DMSO; Molecular Probes, Eugene, OR) for 30 minutes at 37˚C. The cells were then washed twice with PBS and incubated for 30 minutes at 37˚C, and they were mounted in a perfusion chamber that was placed on the stage of a confocal microscope (Zeiss LSM800) at 22 to 24˚C. Purinergic agonists (ATP or a,b-metilATP) were added at the corresponding time at a final concentration of 100 mM in bath solution. Cultured cells were briefly illuminated adjusting laser power (#0.5%) and scan speed (6-7), using the ZEN 2.1 software (Zeiss). Regions of interest were simultaneously selected on neuronal somata containing Fluo-4 fluorescence (laser excitation 480 nm, emission 510 nm) in a field having usually more than 20 cells. Images were collected at 2-second intervals during a continuous 12-minute period. Calcium imaging was carried out in a 16-bit (0-65,000 units of fluorescence scale) with highly sensitive GaAsP detector (Zeiss). The Ca 21 transients, defined by their amplitude that should be greater than 2 times the noise level, were acquired and analyzed offline with ZEN 2.1 software.
Statistical analysis
All experiments were performed a minimum of 3 times. All graphs show the average 6 SEM. Statistical evaluation was performed with GraphPad Prism software, version 6.1 (GraphPad, San Diego, CA). Significant differences between experiments were assessed by an unpaired t test or a 1-way analysis of variance with a Tukey posttest, considering a as 0.05. For electrophysiological experiments, statistical analyses were performed using the nonparametric Mann-Whitney test.
Results
The P2X2aR binds to the Cdk5/p35 complex in heterologous expression system
To study the potential P2X2aR modulation by Cdk5, we first evaluated whether there is an interaction between the P2X2aR and the Cdk5/p35 complex in HEK293 cells co-transfected with Cdk5, p35, and P2X2aR vectors. For this end, we transfected P2X2aR-GFP fusion vector (Fig. 1A) and found that GFP fluorescence from P2X2aR-GFP fusion protein (green) was located mainly on the plasma membrane and it was highly co-localized with P2X2R label (red), allowing us to use GFP fluorescence as a measure of P2X2aR localization (Fig. 1B) . To confirm the specificity of P2X2R antibody, we used a control peptide antigen for P2X2R that was incubated with P2X2R primary antibody, demonstrating that P2X2R label almost disappears, while GFP fluorescence remains (Fig. 1C) . Next, by immunofluorescence using Cdk5 and p35 antibodies, we found that P2X2aR-GFP (green) co-localized with Cdk5 (red) and p35 (blue) immunostaining in close proximity to plasma membrane (Fig. 1D) . In addition, we performed a set of confocal images at different focal planes (0.9 mm each) (Fig. 1E) and an orthogonal reconstruction (Fig. 1F) to find evidence that supports that P2X2aR-GFP, Cdk5, and p35 are interacting with each other, and they were effectively found co-localized in areas near to the plasma membrane. To confirm the specificity of P2X2R antibody in Western blot analysis, we incubated the P2X2R primary antibody in the presence or absence of control peptide antigen, and we observed that the P2X2R bands disappeared in the presence of the peptide in both heterologous expression of P2X2aR transfected HEK293 cells or in endogenous P2X2R expression in PC12 cells ( Fig. 2A) . We also evaluated whether P2X2aR can immunoprecipitate with Cdk5 or p35 in HEK293 cells cotransfected with P2X2aR-pIRES-GFP with p35 or Cdk5 vectors. By immunofluorescence, we observed that P2X2aR expression was localized in plasma membrane and GFP fluorescence was localized in the whole cell (Fig. 2B) . We performed coimmunoprecipitation experiments using HEK293 cells under the following experimental condition: (1) control untransfected cells (UT); (2) cells transfected with P2X2aR-pIRES-GFP vector; (3) cells transfected with P2X2aR-pIRES-GFP plus p35 vectors; and (4) cells transfected with P2X2aR-pIRES-GFP plus His-Cdk5 vectors, and then we confirmed the expression of transfected proteins through Western blots (Fig. 2C) . Using protein extracts from HEK293 cells co-transfected with P2X2aR and p35, or from P2X2aR and His-Cdk5, we immunoprecipitated by using an antip35 antibody (Fig. 2D) or anti-Cdk5 antibody (Fig. 2E) . In the immunocomplexes from both immunoprecipitates, we detected the P2X2aR in Western blot using an anti-P2X2R antibody. As a control of immunoprecipitation, we detected the corresponding Cdk5 and p35 proteins after stripping each membrane. Moreover, as controls for immunoprecipitation assays, we used goat IgG control and no primary antibody (only Protein A/G agarose beads) (Fig. 2D, E) . These results indicate that P2X2aR form a protein complex with Cdk5 and p35 in co-transfected HEK293 cells. The formation of such complex could be independent of mutual presence of Cdk5 and p35. This finding prompted us to investigate if there is a link between the activities of Cdk5 signaling pathway and P2X2aR.
The P2X2aR is a target for Cdk5 phosphorylation
By using the phosphorylation prediction websites Motif-Scan and NetPhos2.0, we identified a putative consensus motif for Cdk5 phosphorylation of (S/T)PX(K/H/R) in the P2X2aR protein sequence. 2 Remarkably, this consensus motif 372 TPKH 375 sequence is present exclusively in the full-length rat P2X2aR but absent in the shorter splice variant P2X2bR (Fig. 3A) . By using P2X2R antibody, we recognized P2X2aR, P2X2bR, and P2X2aR-T372A protein transfected in HEK293 cells (Fig. 3B) . We evaluated whether P2X2aR-Cdk5/p35 interactions result in the phosphorylation of threonine residues, an indication that Cdk5 could directly phosphorylate the P2X2aR. To evaluate this, we immunoprecipitated P2X2aR from transfected HEK293 cells with P2X2aR alone or with p35 vector, by using P2X2R antibody followed by Western blot against phosphothreonine antibody. We found that phosphothreonine signal was significantly increased in cells expressing P2X2aR and p35, as compared with P2X2aR alone (Fig. 3C) . To further study whether this P2X2aR sequence is a phosphorylation target for Cdk5/p35, we generated 10-amino acid peptides containing the threonine Cdk5 motif present in rat, mouse, and human P2X2aRs (Fig. 3D) and tested their phosphorylation potential by an in vitro kinase assay by using recombinant Cdk5/ p35 protein. As a positive control, we used the phosphorylation of histone H1 as measured by the incorporation of 32 P. We found that all 3 P2X2aR-derived peptides were highly phosphorylated by the recombinant Cdk5/p35 complex with 45.9% for human P2X2aR, 56.3% for mouse P2X2aR, and 64.0% for rat P2X2aR as compared with histone H1 phosphorylation (100%). A nonrelated 10-amino acid peptide was used as negative control for Cdk5 activity and it was 1 order of magnitude less phosphorylated (3.4%) than P2X2aR peptides (Fig. 3D) . These experiments also showed that in vitro phosphorylation of P2X2aR-derived peptides from human, rat, and mouse occurred at the same extent when using similar experimental conditions.
Cdk5 activation regulates P2X2aR desensitization
We tested if this interaction between the P2X2aR and Cdk5/p35 has any functional effects. For this purpose, we studied the patterns of currents generated by P2X2aR activation using electrophysiological techniques and tested Cdk5-mediated changes in those currents.
As we have previously demonstrated, the P2X2R has a unique property, an increase in receptor desensitization rate after repetitive ATP applications that is termed use-dependent desensitization (UDD). 14, 27 In HEK293 cells expressing the P2X2aR and measured under the whole-cell configuration, receptor desensitization increased after repetitive 10 mM ATP applications in the presence of extracellular Ca 21 (Fig. 4A) . Cells co-expressing the P2X2aR and p35 still showed UDD although the percentage of desensitization in the third and fourth ATP application was significantly smaller (Fig.  4A , C, n 5 6, P , 0.05). In contrast, no difference in the development of UDD was found between cells expressing the P2X2bR alone or co-expressed with p35 (Fig. 4B, D, n 5 6 ). Activation of Cdk5 by transfection of p35 did not affect the current amplitudes of both receptors (Fig. 4E, F) . Afterwards, we wanted to test these effects in Xenopus laevis oocytes, a different heterologous expression system. The increase in receptor desensitization in oocytes was significantly lower, and only after four 100 mM ATP applications a modest increase in receptor desensitization was observed (Fig. 5A, B) . However, co-expression of P2X2aR and p35 prevented the modest increase in desensitization observed at the fourth 100 mM ATP application (Fig. 5A, B, E) , suggesting a role of Cdk5 in this effect. No differences in ATP EC 50 (Fig. 5C ) nor in maximal current (Fig. 5D) were observed when the P2X2aR was expressed alone or together with p35. Finally, treatment with the Cdk5 inhibitor roscovitine (30 mM, incubated for 3 hours before the experiment) reverted the effect of Cdk5 activation and restored the desensitization observed in the P2X2aR alone (Fig. 5E) . Thus, Cdk5-mediated phosphorylation should be responsible for P2X2aR desensitization.
To disrupt the putative Cdk5 phosphorylation site of the P2X2aR, 372 TPKH 375 , we generated the P2X2aR-T372A mutant. This mutant was successfully expressed in the plasma membrane of HEK293 cells and was indistinguishable from wild-type P2X2aR, as measured by immunofluorescence experiment (Fig.  6A, B) . In addition, this mutant has similar molecular weight as compared with wild-type P2X2aR (Fig. 3B) . In functional experiments, the whole-cell current elicited by ATP desensitized with an average t des of 10.3 6 1.2 seconds, but no further increases in UDD were observed as compared to the wild-type P2X2aR in HEK293 transfected cells (Fig. 6C) . Next, we overexpressed both the wild-type P2X2aR and the T372A mutant in PC12 cells during 24 hours, and we observed similar results to that obtained with HEK293 cells (Fig. 6D) . Similar to what we observed for wild-type P2X2aR, when the T372A mutant was expressed in oocytes, the rates of receptor desensitization were slower than in HEK293 cells (Fig. 6E) . In addition, ATP affinity was not significantly affected by this mutation (14.6 6 2.5 mM in T372A vs 17.7 6 0.7 mM in wild-type P2X2aR; Fig. 6F) , and the maximal currents 
(D and E) Immunoprecipitation experiments of HEK293 cells expressing P2X2aR-pIRES-GFP and p35; or P2X2aR-pIRES-GFP and Cdk5. For immunoprecipitation, we used p35 rabbit (C19) antibody (D) and Cdk5 mouse (DC17) antibody (E)
, and we detected P2X2aR by using P2X2R rabbit antibody by Western blot. As a positive control, the corresponding Cdk5 and p35 proteins were detected after stripping of each membrane. For a control with no antibody, we only used Protein A/G agarose beads and we did not find the P2X2aR in those immunocomplexes. We used normal IgG goat antibody as IgG control. Cdk5, cyclin-dependent kinase 5. were affected only in oocytes but not in HEK293 cells (Fig. 6G) . We hypothesize that the mutation induces important structural changes that affects the receptor gating, rendering a lessdesensitizing phenotype and preventing the effect of Cdk5 activation as observed in wild-type receptors. To confirm that the T372A mutation did not alter other features of P2X2aR gating, we studied the effects of several allosteric modulators and one antagonist of this receptor. The typical potentiation of ATP-gated currents of P2X2aR induced by copper, zinc, and protons was conserved in the T372A mutant as well as the inhibition induced by PPADS (Fig. 6H) . Finally, co-expression of the T372A mutant and p35 did not affect receptor desensitization in both HEK293 cells and oocytes (Fig. 6H) . Thus, these results suggest that Cdk5-mediated phosphorylation of the P2X2aR at Thr372 can mainly affect the desensitization of this receptor channel.
P2X2R interacts with Cdk5/p35 complex in nociceptive mouse tissues
To evaluate whether P2X2R is also interacting with Cdk5 and p35 in relevant physiological tissues, we performed primary cultures of neurons from mouse DRG and TG. After 2 days of culture, by using immunofluorescence and confocal microscopy we detected that P2X2R (green) is expressed exclusively in a subset of TG (Fig. 7A, C) and DRG (Fig. 7B, D) neurons colocalizing with p35 (arrows, Fig. 7A, B) or Cdk5 (arrows, Fig. 7C,  D) . The expression of Cdk5 and p35 (red) was predominant in neurons, labeled with bIII-tubulin or Map1B antibodies (white). Cdk5 and p35 were also detected in other cell types present in our primary culture setup although showing reduced relative signal intensity (Fig. 7A-D) . We also detected co-localization of P2X2R with p35 (Fig. 7E) or P2X2R with Cdk5 (Fig. 7F) in neurites from primary culture TG neurons. Moreover, by using RT-PCR, we detected that mouse TG and DRG expressed messenger RNA of P2X2R isoforms (P2X2aR, P2X2bR, and P2X2eR), P2X3R, Cdk5, and p35 (Fig. 7G) . In addition, by using Western blot we detected several bands of P2X2R (between 55 and 72 kDa) from mouse TG and DRG tissues, according to splice variants and a different degree of glycosylation. 39 We also detected P2X3R, Cdk5, and p35 by Western blot from these tissues (Fig. 7H) . Finally, we immunoprecipitated extracts from mouse TG by using a rabbit anti-Cdk5 antibody and detected P2X2R in Western blot using a rabbit anti-P2X2R antibody. As a control for immunoprecipitation, we detected Cdk5 protein after stripping the membrane. As a control with no primary antibody, we only used Protein A/G agarose beads and we did not find P2X2R in those immunocomplexes (Fig. 7I) . Altogether, these results indicate that endogen P2X2R interacts with Cdk5 in mouse TG and that P2X2R co-localize with Cdk5 and p35 in TG and DRG neurons, suggesting that Cdk5 might play an important role in physiological modulation of P2X2R, implicating its role in pain signaling. 
Endogenous P2X2R-mediated currents are regulated by endogenous Cdk5 activity
In a following set of experiments, we tested whether Cdk5 regulation could be relevant in a system that expresses both proteins endogenously by means of electrophysiology. We chose for this purpose neuronal-like PC12 cells, a cell line derived from rat pheochromocytoma that was the original source for the first P2X2R cloned 4 ( Fig. 2A) . These cells also endogenously express p35 and Cdk5. 23, 53 Undifferentiated PC12 cells exhibit ATP-mediated currents that match with the desensitization profile of the slow desensitizing P2X2aR (t des 5 22.9 6 3.4 seconds; Fig. 8A, B) .
When cells were treated with roscovitine (30 mM) for 6 or 24 hours to inhibit the endogenous Cdk5 activity, currents desensitized significantly faster (t des 6 hours 5 7.1 6 2.5 seconds; t des 24 hours 5 9.0 6 2.0 seconds; Fig. 8A, B) , without significantly altering the current densities (Fig. 8C) , further confirming the role of Cdk5 in regulating the gating properties of the P2X2aR.
The desensitization of the heteromeric P2X2/3R is also modulated by Cdk5/p35
In a final set of experiments, we tested the effects of Cdk5 on heteromeric P2X2/3Rs, which is the main purinergic subtype, expressed in pain pathways. In HEK293 cells co-transfected with the P2X2aR and the P2X3R, we evoked heteromeric currents by using the specific agonist a,b-meATP that induces the typical slow desensitizing P2X2/3R-mediated currents (Fig.  8D) ; when p35 was co-transfected with both P2XRs, the resulting current desensitized slower than the one mediated by the P2X2/3R alone, with desensitization constants of 10.7 6 1.9 and 5.8 6 0.8 seconds, respectively (Fig. 8D, E) , without significantly altering the current densities (Fig. 8F) . To test the physiological relevance of this phenomenon, we first performed primary cultures of mouse TG (Fig. 9A) and DRG neurons (Fig.  9B) for 2 days and we observed co-localization of P2X2R (red) with P2X3R (green) by immunofluorescence. Later on, in acute primary cultures of rat TG, we measured the endogenous P2X2/ 3R-mediated responses by means of Ca 21 imaging. Adenosine triphosphate evoked strong responses of TG neurons, as reflected by the increases in fluorescence induced by ATP in Fluo-4 loaded neurons (Fig. 9C) . Adenosine triphosphate, a general purinergic agonist, activated in average a 30% of the stimulated neurons (Fig. 9D) . Interestingly, when a,b-meATP was used, a P2X3R and P2X2/3R agonist, only an 8% of the TG neurons responded (Fig. 9D) . The responding cells presented 2 main types of responses, a fast spike (black tracing), probably reflecting the activation of a homomeric P2X3R, and a slower spike (red tracing), that could reflect the activation of the P2X2/ 3R (Fig. 9E) . Finally, when TG neurons were treated with roscovitine (20 mM, 6 hours), we observed a greater number of fast spike responses (Fig. 9F ) that resulted in a decrease of the decay constant (Fig. 9G) without affecting the percentage of responding cells (Fig. 9H) nor the relative amplitude (Fig. 9I) of the a,b-meATP-evoked responses.
Discussion
In the present study, we showed a functional interaction between the P2X2aR and the Cdk5/p35 complex. Moreover, the currents mediated by this channel are regulated by the activation of Cdk5, which prevents the development of UDD in whole-cell patchclamp recordings. We suggest that the phosphorylation of the intracellular P2X2aR residue Thr372 by Cdk5/p35 delays the receptor desensitization and such modulation can be physiologically important, especially in pain signaling pathways where both proteins are interacting, as our experiments in PC12 cells and TG neurons strongly suggest.
Phosphorylation and dephosphorylation are common processes that regulate diverse protein functions, including the gating of plasma membrane channels; a number of reviews have summarized the effects of phosphorylation in voltagegated channels and in NMDA, GABA, TRP, and ACh receptors. 10, 37, 45, 50 The P2XR gating is also modulated by phosphorylation and dephosphorylation. For example, it has been suggested that PKA regulates P2X2R and P2X3R function, inhibiting the currents mediated by the former and potentiating the latter. 16, 59 In the case of the P2X4R, PKA seems to regulate the receptor trafficking through an accessory protein. 6 PKC has also been suggested as a regulator of P2XR activity, an effect that for the P2X1R can be mediated by the activation of G-protein-coupled receptors. 1 Additionally, there is evidence suggesting an effect of PKC on P2X3R. 43 A recent study has shown that calmodulin kinase II can regulate the P2X3R trafficking from and to the plasma membrane. 15 Src tyrosine kinase has also been suggested to regulate the P2X3R, decreasing the receptor-mediated currents through the intracellular Tyr393. 17 Cyclin-dependent kinase 5 regulates TRPV1 channel function by direct phosphorylation at Thr407, increasing the Ca 21 -influx mediated by this channel 25, 33, 40, 47 and by phosphorylation of kinesin 13B (KIF13B) motor that increases TRPV1 trafficking to the plasma membrane. 61 In this context, the results showed here are in agreement with previous Cdk5 mechanism of action in the pathways of pain signaling. 52 Thus, Cdk5-mediated P2X2aR phosphorylation on Thr372 will modify the degree of desensitization of the channels that will finally result in an increased depolarization and increased of Ca 21 influx in the nociceptive neurons. Contrary to TRPV1 and P2X2aR, Cdk5 activation seems to downregulate P2X3R function through the serine phosphorylation of an unidentified accessory protein. 38 This could reflect a differential regulation of homomeric P2X3Rs and heteromeric P2X2/3Rs, that are the subtypes mainly expressed in nociceptive neurons; future functional experiments in nociceptive DRG or TG neurons will help to clarify the role of Cdk5 regulation in these 2 P2XR channel subtypes.
In the present study, our results support a direct interaction of the P2X2aR with Cdk5 and p35. Co-immunolocalization experiments showed a marked overlap between P2X2aR and Cdk5/ p35 signals in both heterologous systems and endogenous protein levels as we found in mouse TG and DRG neurons; this was further supported by co-immunoprecipitation experiments, suggesting that P2X2aR can interact with both Cdk5 and p35. Additionally, we also found that P2X2aR and Cdk5/p35 not only are physically close, but also that their interaction increases threonine phosphorylation. Moreover, the Cdk5 consensus motif 372 TPKH 375 is only present in the rat P2X2aR but not in the splice variant P2X2bR. We identified this sequence as part of the canonical consensus sequence (S/T)PX(K/H/R) present in target proteins that are phosphorylated by Cdk5, 2 and we confirmed that this sequence can be a phosphorylation target by the synthesis of peptides containing this sequence and the homologous Cdk5 consensus motifs present in human, rat, and mouse P2X2aRs; all of these peptides were phosphorylated by the Cdk5/p35 complex, indicating that they can effectively reflect a phosphorylation site in the P2X2aR C-terminal domain. We tested if the Cdk5-mediated phosphorylation of the P2X2aR could have functional consequences in the activity of this channel, by means of electrophysiological recordings. We found that the activation of endogenous Cdk5, by the expression of its activator p35, significantly prevented P2X2aR desensitization after repetitive ATP applications. We have previously shown that the P2X2aR increases its desensitization rates after successive ATP applications, arising a Ca 21 -dependent process termed UDD. 14, 27 The most plausible explanation for this phenomenon is that Cdk5 phosphorylation favors a nondesensitized phenotype and protects the receptor for the Ca 21 -dependent UDD. We have previously showed that UDD requires the presence of Ca 21 in a nanomolar or less concentration to be observed in whole-cell recordings, 14 and this could reflect the loss of some relevant cytosolic factor to determine P2X2aR desensitization. This can explain the differences observed in the recordings performed in HEK293 cells and Xenopus oocytes, although future experiments will help to completely clarify the mechanism of P2X2aR desensitization. When experiments were performed in Xenopus oocytes, a recording system that preserves the intracellular components, we also observed a prevention of P2X2aR increase in desensitization after Cdk5 activation and this effect was blocked by the Cdk5 inhibitor roscovitine, although desensitization was remarkably smaller than in whole-cell patch-clamp recordings. Moreover, the mutation of T372A prevented the development of UDD in whole-cell recordings in HEK293 cells and inhibited the increase of desensitization in 2-electrode voltage-clamp recordings in oocytes, suggesting the critical role of this residue in this phenomenon. Although we initially expected that this mutant would render more desensitized profiles of currents, we hypothesize that the mutation induced a structural change that probably resulted in this particular phenotype. Although the T372A mutation obliterated the increases in receptor desensitization regardless of the expression system used, it is obvious that the desensitization observed varied depending on the cell host, showing a higher desensitization profile in HEK293 cells as compared to PC12 cells and Xenopus oocytes. We infer that these differences could be the result of particular features of each expression system, but despite that, we confirm that the mutant T372A preserved most of the features characteristic of the P2X2aR, supporting our findings in the present work.
Remarkably, the experiments in PC12 cells and in primary cultures of TG neurons strongly suggest that Cdk5-mediated regulation of the P2X2R could be physiologically relevant. PC12 cells endogenously express P2X2R, Cdk5, and p35 4, 23, 53 ; we inferred that if that being the case, the P2X2R-mediated currents are basally phosphorylated by Cdk5, rendering currents with slow desensitization kinetics. As expected, Cdk5 inhibition by roscovitine accelerated the desensitization of P2X2R-mediated currents, in agreement with the results obtained in heterologous systems. Finally, we studied the effects of Cdk5 phosphorylation on the heteromeric P2X2/3R that is the main purinergic receptor involved in pain transmission. 31 Currently, there is no published information if all the splice P2X2R variants can indeed form heteromeric receptors, but we have preliminary data that at least rat P2X2bR is able to form functional heteromeric channels (Dr. Stanko Stojilkovic, June 2013, oral communication). As the homomeric P2X2aR, the desensitization properties of the P2X2/ 3R were affected by Cdk5 phosphorylation as demonstrated by both electrophysiology of heterologous expressed P2X2/3Rs in HEK293 cells and by Ca 21 imaging of endogenous P2X2/3Rs from primary cultures of TG neurons that also express endogenously p35 and Cdk5. These results strongly suggest a physiological relevance of Cdk5 regulation of purinergic receptors, especially in pain transduction. P2X2/3Rs are commonly formed by 2 P2X3 subunits and 1 P2X2 subunit 26 ; however, a recent article has shown that the P2X3(P2X2) 2 stoichiometry also results in functional channels 29 ; we infer that these receptors will be even more susceptible to Cdk5 regulation.
In general, the effects of phosphorylation on membrane receptors and channels can be exerted through direct regulation of the channel gating properties, resulting in a greater or smaller conductance or in a change of voltage dependence or in the agonist's EC 50 , as it has been observed for Kv2.1 or TRPV1 channels. 36, 42 Other described effects of channel phosphorylation o dephosphorylation are channel internalization and/or changes in trafficking and degradation, as for example, AMPA and NMDA glutamate receptors. 24, 32 Interestingly, it has also been reported that a phosphorylation and dephosphorylation can regulate the desensitization of NMDA receptors, by regulating the number of functional channels in the membrane. 58 In our study, it seems that Cdk5 phosphorylation does not affect the number of functional channels (it has no effect on current amplitudes), but rather it affects the desensitization properties by changing its gating properties because we did not observe changes in the maximal currents nor in ATP EC 50 after Cdk5 activation. Accordingly, we did not observe a significant increase in the protein levels of the P2X2aR in immunoblots when the receptor was co-expressed with p35 or Cdk5; however, future studies will be conducted to explore P2X2aR trafficking to the plasma membrane when Cdk5 is highly activated. There is evidence showing that Cdk5 regulate the activation of several ion channels and membrane receptors, suggesting a role during peripheral and central sensitization in pain pathways. 21, 47, 52, 60 For example, Cdk5 can phosphorylate NMDA receptors at Ser1232 of the NR2A subunit 32 and regulate its surface expression through NR2B subunit phosphorylation. 44 P/Q-type voltage-dependent Ca 21 channels are also targets for Cdk5 phosphorylation, a process that regulates neurotransmitter release. 51 In summary, we have identified a novel mechanism of regulation of P2X2R desensitization by Cdk5-mediated phosphorylation, and we have presented evidence that this regulation could be relevant in pain signaling, such as P2X2/3R-mediated responses in TG neurons. Future efforts should be focused on characterizing the mechanism of P2X2aR desensitization and whether phosphorylation and Ca 21 -mediated effects are related. Our findings suggest that the P2X2aR is a novel substrate for Cdk5-mediated phosphorylation, which might play an important role in the physiological processes such as pain signaling and therefore could be a potential novel target for developing pain therapies.
